首页> 外文期刊>Journal of breath research >The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva
【24h】

The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva

机译:人体挥发物:呼出气,皮肤散发,尿液,粪便和唾液中的挥发性有机化合物(VOC)

获取原文
获取原文并翻译 | 示例
           

摘要

Breath analysis is a young field of research with its roots in antiquity. Antoine Lavoisier discovered carbon dioxide in exhaled breath during the period 1777–1783, Wilhelm (Vilém) Petters discovered acetone in breath in 1857 and Johannes Müller reported the first quantitative measurements of acetone in 1898. A recent review reported 1765 volatile compounds appearing in exhaled breath, skin emanations, urine, saliva, human breast milk, blood and feces. For a large number of compounds, real-time analysis of exhaled breath or skin emanations has been performed, e.g., during exertion of effort on a stationary bicycle or during sleep. Volatile compounds in exhaled breath, which record historical exposure, are called the ‘exposome’. Changes in biogenic volatile organic compound concentrations can be used to mirror metabolic or (patho)physiological processes in the whole body or blood concentrations of drugs (e.g. propofol) in clinical settings—even during artificial ventilation or during surgery. Also compounds released by bacterial strains like Pseudomonas aeruginosa or Streptococcus pneumonia could be very interesting. Methyl methacrylate (CAS 80–62–6), for example, was observed in the headspace of Streptococcus pneumonia in concentrations up to 1420 ppb. Fecal volatiles have been implicated in differentiating certain infectious bowel diseases such as Clostridium difficile, Campylobacter, Salmonella and Cholera. They have also been used to differentiate other non-infectious conditions such as irritable bowel syndrome and inflammatory bowel disease. In addition, alterations in urine volatiles have been used to detect urinary tract infections, bladder, prostate and other cancers. Peroxidation of lipids and other biomolecules by reactive oxygen species produce volatile compounds like ethane and 1-pentane. Noninvasive detection and therapeutic monitoring of oxidative stress would be highly desirable in autoimmunological, neurological, inflammatory diseases and cancer, but also during surgery and in intensive care units. The investigation of cell cultures opens up new possibilities for elucidation of the biochemical background of volatile compounds. In future studies, combined investigations of a particular compound with regard to human matrices such as breath, urine, saliva and cell culture investigations will lead to novel scientific progress in the field.
机译:呼吸分析是一个年轻的研究领域,其起源可追溯到古代。 Antoine Lavoisier在1777年至1783年间发现了呼出气中的二氧化碳,Wilhelm(Vilém)Petters在1857年发现了呼气中的丙酮,JohannesMüller于1898年报告了第一批丙酮的定量测量结果。最近的一项评论报道,呼出气中出现了1765种挥发性化合物,皮肤排泄物,尿液,唾液,人乳,血液和粪便。对于大量化合物,例如在固定自行车上努力工作或睡眠期间,已经进行了呼气或皮肤散发的实时分析。记录了历史暴露的呼出气中的挥发性化合物称为“暴露体”。在临床环境中,甚至在人工通气或手术过程中,生物挥发性有机化合物浓度的变化可用于反映整个体内的代谢或(病理)生理过程或药物(例如丙泊酚)的血液浓度。由铜绿假单胞菌或肺炎链球菌等细菌菌株释放的化合物也可能非常有趣。例如,在肺炎链球菌的顶部空间中观察到甲基丙烯酸甲酯(CAS 80–62–6)的浓度高达1420 ppb。粪便中的挥发物与鉴别某些传染性肠道疾病有关,例如艰难梭菌,弯曲杆菌,沙门氏菌和霍乱。它们也已用于区分其他非感染性疾病,例如肠易激综合症和炎症性肠病。此外,尿液挥发物的变化已被用于检测尿路感染,膀胱癌,前列腺癌和其他癌症。脂质和其他生物分子被活性氧过氧化会产生挥发性化合物,如乙烷和1-戊烷。在自体免疫,神经,炎性疾病和癌症中,以及在手术期间和重症监护病房中,非常需要对氧化应激进行无创检测和治疗性监测。细胞培养物的研究为阐明挥发性化合物的生化背景开辟了新的可能性。在未来的研究中,针对特定化合物的人类基质(如呼吸,尿液,唾液和细胞培养等)的联合研究将在该领域带来新的科学进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号